Evaluation of Exacerbation and Symptom-Free Time in Patients with COPD

References

• GOLD. Global Initiative for Chronic Obstructive Lung Disease, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). Pneumologie. 2020;71:1–141.
   Google Scholar
• Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med. 2020;173(3):ITC17–ITC32. DOI:10.7326/AITC202008040
   PubMed Web of Science ®Google Scholar
• Viniol C, Vogelmeier CF. Exacerbations of COPD. Eur Respir Rev. 2018;27(147):170103. DOI:10.1183/16000617.0103-2017
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. DOI:10.1016/S0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• Aaron SD, Donaldson GC, Whitmore GA, et al. Time course and pattern of COPD exacerbation onset. Thorax. 2012;67(3):238–243. DOI:10.1136/thoraxjnl-2011-200768
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Patel IS, et al. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J. 2003;22(6):931–936. DOI:10.1183/09031936.03.00038303
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. DOI:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Foo J, Landis SH, Maskell J, et al. Continuing to confront COPD international patient survey: economic impact of COPD in 12 countries. PLoS One. 2016;11(4):e0152618–15. DOI:10.1371/journal.pone.0152618
   PubMed Web of Science ®Google Scholar
• Beeh KM, Glaab T, Stowasser S, et al. Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial. Respir Res. 2013;14(1):116–118. DOI:10.1186/1465-9921-14-116
   PubMedGoogle Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. DOI:10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• Rutten-Van Mölken MPMH, Postma MJ, Joore MA, et al. Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands. Respir Med. 1999;93(11):779–787. DOI:10.1016/S0954-6111(99)90262-7
   PubMed Web of Science ®Google Scholar
• Anecchino C, Rossi E, Fanizza C, et al. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis. 2007;2(4):567–574.
   PubMedGoogle Scholar
• Vanfleteren LEGW, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–735. DOI:10.1164/rccm.201209-1665OC
   PubMed Web of Science ®Google Scholar
• Chatila WM, Thomashow BM, Minai OA, et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):549–555. DOI:10.1513/pats.200709-148ET
   PubMedGoogle Scholar
• Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454–475. DOI:10.1183/09059180.00008612
   PubMedGoogle Scholar
• Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888.
   PubMed Web of Science ®Google Scholar
• Hillas G, Perlikos F, Tsiligianni I, et al. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109.
   PubMed Web of Science ®Google Scholar
• Beghé B, Verduri A, Roca M, et al. Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD. Eur Respir J. 2013;41(4):993–995. DOI:10.1183/09031936.00180812
   PubMed Web of Science ®Google Scholar
• Patel ARC, Donaldson GC, Mackay AJ, et al. The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. Chest. 2012;141(4):851–857. DOI:10.1378/chest.11-0853
   PubMed Web of Science ®Google Scholar
• Huang J, Bian Y, Zhao Y, et al. The impact of depression and anxiety on chronic obstructive pulmonary disease acute exacerbations: a prospective cohort study. J Affect Disord. 2021;281:147–152. DOI:10.1016/j.jad.2020.12.030
   PubMed Web of Science ®Google Scholar
• Anzueto AR, Calverley PMA, Wise RA, et al. Assessing COPD profiles and outcomes by dyspnoea severity. Eur Respir J. 2016;48:PA4057. DOI:10.1183/13993003.congress-2016.PA4057
   Web of Science ®Google Scholar
• Jones PW, Watz H, Wouters EFM, et al. COPD: the patient perspective. Int J Chron Obstruct Pulmon Dis. 2016;11:13–20.
   PubMedGoogle Scholar
• Celli BR, ATS/ERS Task Force for COPD Research, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, et al. An official American thoracic society/european respiratory society statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):e4–27–e27. DOI:10.1164/rccm.201501-0044ST
   Web of Science ®Google Scholar
• Reardon JZ. COPD and exercise: What’s really important? A nursing perspective. COPD. 2007;4(3):283–287. DOI:10.1080/15412550701480570
   PubMedGoogle Scholar
• Linnell J, Hurst JR. COPD exacerbations: a patient and physician’s perspective. Adv Ther. 2020;37(1):10–16. DOI:10.1007/s12325-019-01138-7
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Román-Rodríguez M, Singh D, et al. Goals of COPD treatment: Focus on symptoms and exacerbations. Respir Med. 2020;166:105938. DOI:10.1016/j.rmed.2020.105938
   PubMed Web of Science ®Google Scholar
• Doornenbal BM, Vos RC, van Vliet M, et al. Measuring positive health: Concurrent and factorial validity based on a representative Dutch sample. Health Soc Care Commun. 2021;30(5):2109–2117.
   Google Scholar
• Huber M, van Vliet M, Giezenberg M, et al. Towards a “patient-centred” operationalisation of the new dynamic concept of health: a mixed methods study. BMJ Open. 2016;6(1):e010091. DOI:10.1136/bmjopen-2015-010091
   PubMed Web of Science ®Google Scholar
• Sigurgeirsdottir J, Halldorsdottir S, Arnardottir RH, et al. COPD patients’ experiences, self-reported needs, and needs-driven strategies to cope with self-management. Int J Chron Obstruct Pulmon Dis. 2019;14:1033–1043. DOI:10.2147/COPD.S201068
   PubMed Web of Science ®Google Scholar
• van Stel HF, Colland VT, Heins NL, et al . Patient’s view of outcome in pulmonary rehabilitation. J Cardiopulm Rehabil. 2022;22:201–210.
   Google Scholar
• Boer LM, Bischoff EW, Borgijink X, et al. Exacerbation-free time” to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study. NPJ Prim Care Respir Med. 2018;28(1):8–13.
   PubMedGoogle Scholar
• Effing T, Kerstjens H, van der Valk P, et al. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax. 2009;64(11):956–962. DOI:10.1136/thx.2008.112243
   PubMed Web of Science ®Google Scholar
• Lenferink A, van der Palen J, van der Valk P, et al. Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial. Eur Respir J. 2019;54(5):1802134. DOI:10.1183/13993003.02134-2018
   PubMed Web of Science ®Google Scholar
• Lenferink A, Frith P, van der Valk P, et al. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with chronic obstructive pulmonary disease (COPD) and comorbidities: the COPE-III study protocol. Contemp Clin Trials. 2013;36(1):81–89. DOI:10.1016/j.cct.2013.06.003
   PubMed Web of Science ®Google Scholar
• Munari AB, Gulart AA, dos Santos K, et al. Modified medical research council dyspnea scale in GOLD classification better reflects physical activities of daily living. Respir Care. 2018;63(1):77–85. DOI:10.4187/respcare.05636
   PubMed Web of Science ®Google Scholar
• Schünemann HJ, Goldstein R, Mador MJ, et al. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J. 2005;25(1):31–40.
   PubMed Web of Science ®Google Scholar
• Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1(1):29–29. DOI:10.1186/1477-7525-1-29
   PubMedGoogle Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422. DOI:10.1164/ajrccm.157.5.9709032
   PubMed Web of Science ®Google Scholar
• Blanco-Aparicio M, Vázquez I, Pita-Fernández S, et al. Utility of brief questionnaires of health-related quality of life (Airways Questionnaire 20 and Clinical COPD Questionnaire) to predict exacerbations in patients with asthma and COPD. Health Qual Life Outcomes. 2013;11(1):85–11. DOI:10.1186/1477-7525-11-85
   PubMed Web of Science ®Google Scholar
• Moradkhani B, Mollazadeh S, Niloofar P, et al. Association between medication adherence and health-related quality of life in patients with chronic obstructive pulmonary disease. J Pharm Health Care Sci. 2021;7(1):40. DOI:10.1186/s40780-021-00222-x
   PubMed Web of Science ®Google Scholar
• Baiardini I, Contoli M, Corsico AG, et al. Exploring the relationship between disease awareness and outcomes in patients with chronic obstructive pulmonary disease. Respiration. 2021;100(4):291–297. DOI:10.1159/000513953
   PubMed Web of Science ®Google Scholar
• Baghai-Ravary R, Quint JK, Goldring JJP, et al. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med. 2009;103(2):216–223. DOI:10.1016/j.rmed.2008.09.022
   PubMed Web of Science ®Google Scholar
• Kentson M, Tödt K, Skargren E, et al. Factors associated with experience of fatigue, and functional limitations due to fatigue in patients with stable COPD. Ther Adv Respir Dis. 2016;10(5):410–424. DOI:10.1177/1753465816661930
   PubMed Web of Science ®Google Scholar
• Ebadi Z, Goërtz YMJ, van Herck M, et al. The prevalence and related factors of fatigue in patients with copd: a systematic review. Eur Respir Rev. 2021;30(160):200298. DOI:10.1183/16000617.0298-2020
   PubMed Web of Science ®Google Scholar
• Kapella MC, Larson JL, Patel MK, et al. Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease. Nurs Res. 2006;55(1):10–17.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1):67. DOI:10.1186/s12931-017-0548-3
   PubMed Web of Science ®Google Scholar
• Schrijver J, Effing TW, Brusse-Keizer M, et al. Predictors of patient adherence to COPD self-management exacerbation action plans. Patient Educ Couns. 2021;104(1):163–170. DOI:10.1016/j.pec.2020.06.015
   PubMed Web of Science ®Google Scholar
• Bischoff EWMA, Hamd DH, Sedeno M, et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax. 2011;66(1):26–31. DOI:10.1136/thx.2009.127621
   PubMed Web of Science ®Google Scholar
• Trappenburg JCA, Monninkhof EM, Bourbeau J, et al. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax. 2011;66(11):977–984. DOI:10.1136/thoraxjnl-2011-200071
   PubMed Web of Science ®Google Scholar
• Lenferink A, Brusse-Keizer M, van der Valk P, et al. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;8(8):011682.
   Google Scholar